0 items USD 0.00Search
- Did you mean
- global intravenous thrombosis (vte)
Your search for "Global Venous thromboembolism (VTE)" gave back 48393 results.
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The Venous Thromboembolism (VTE) Therapeutics industry plays a crucial role in preventing and treating VTE, a condition characterized by blood clots...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Rivaroxaban market size was valued at USD 8226.5 million in 2023 and is forecast to a readjusted size of USD 13960 million by 2030 with a...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Rivaroxaban market size was valued at US$ 7821.1 million in 2023. With growing demand in downstream market, the Rivaroxaban is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Summary Rivaroxaban market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
November 2020
Price: USD 2,960.00
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Injectable Anticoagulants market size was valued at USD 6268.4 million in 2023 and is forecast to a readjusted size of USD 7205.2 million...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Venous Thromboembolism Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Venous...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The Venous Thromboembolism Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Venous Thromboembolism Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
